Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pluristem Completes New Manufacturing Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pluristem Completes New Manufacturing Facility

Initiates final validation steps

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pluristem Therapeutics, Inc. has initiated the final validation steps for its new manufacturing facility, including the validation of several installation systems such as heating, ventilation and air conditioning (HVAC), water, oil free air and sterile room systems.
 
Zami Aberman, chairman and chief executive officer of Pluristem, said, “I am extremely proud of our team in meeting milestones for the completion of the world’s first commercial cell therapy manufacturing facility. Assuming the PLX cells product candidates are successfully developed and approved by the regulators, we believe that the new facility would have the capacity to produce PLX cells for the treatment of over 150,000 patients annually estimated by Pluristem at $1 billion in production value. Additionally, as clinical trials are approved by regulators for additional indications, our new facility will enable us to supply PLX cells to conduct these trials in parallel.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics